HIGHLIGHTS
- who: Na Shen and colleagues from the Department of Hematology, Afliated Hospital of Hebei Engineering University, Handan, Hebei, China have published the article: Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma, in the Journal: International Journal of Clinical Practice of 25/08/2022
- what: Tus, this study was designed to investigate the expression and prognostic value of PIK3CA, VEGF, IL-8, IL10, and RIP2 in DLBCL.
SUMMARY
Non-Hodgkin lymphoma is one of the most highly heterogeneous malignant neoplasms in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.